期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
奥希替尼联合贝伐珠单抗在获得性EGFR T790M突变晚期非小细胞肺癌的疗效分析 被引量:23
1
作者 顾艳斐 田笑如 +4 位作者 王若天 李小雪 钱坤 李元博 农靖颖 《中国肺癌杂志》 CAS CSCD 北大核心 2022年第12期843-851,共9页
背景与目的奥希替尼是对表皮生长因子受体(epidermal growth factor receptor,EGFR)T790M突变非小细胞肺癌(non-small cell lung cancer,NSCLC)有效的第三代靶向药物。尽管第一代EGFR酪氨酸激酶抑制剂(EGFRtyrosine kinase inhibitors,E... 背景与目的奥希替尼是对表皮生长因子受体(epidermal growth factor receptor,EGFR)T790M突变非小细胞肺癌(non-small cell lung cancer,NSCLC)有效的第三代靶向药物。尽管第一代EGFR酪氨酸激酶抑制剂(EGFRtyrosine kinase inhibitors,EGFR-TKIs)联合贝伐珠单抗治疗可延长无进展生存期(progression-free survival,PFS),但奥希替尼联合贝伐珠单抗的后线疗效在II期研究WJOG8715L中并未得到肯定,目前该联合模式在中国人群中的数据仍非常有限。本研究旨在分析真实世界中奥希替尼联合贝伐珠单抗二线治疗的疗效,评价奥希替尼联合抗血管治疗模式在EGFR T790M获得性耐药突变NSCLC中的二线治疗价值。方法收集2020年1月-2021年8月收治的第一、二代EGFR-TKIs治疗后伴EGFR T790M突变NSCLC患者共42例。16例接受二线奥希替尼联合贝伐珠单抗治疗,另26例接受二线奥希替尼单药治疗。分析患者的治疗效果。结果联合组和单药组客观缓解率(objective response rate,ORR)相当(43.8%vs 50.0%,P=0.694)。两组中位PFS(14.0个月vs 13.0个月,P=0.797)和总生存期(overall survival,OS)(29.0个月vs 26.0个月,P=0.544)均未见统计学差异。Cox回归模型显示前线联合贝伐珠单抗治疗是奥希替尼后线单药或联合治疗PFS(P=0.045)及OS(P=0.023)更短的独立预测因素。结论奥希替尼联合贝伐珠单抗二线治疗相比靶向单药治疗未见更好的疗效。 展开更多
关键词 肺肿瘤 表皮生长因子受体 血管内皮生长因子 奥希替尼 贝伐珠单抗
在线阅读 下载PDF
Ellipsoidal bounding set-membership identification approach for robust fault diagnosis with application to mobile robots 被引量:7
2
作者 Bo Zhou kun qian +1 位作者 Xudong Ma Xianzhong Dai 《Journal of Systems Engineering and Electronics》 SCIE EI CSCD 2017年第5期986-995,共10页
A robust fault diagnosis approach is developed by incorporating a set-membership identification (SMI) method. A class of systems with linear models in the form of fault related parameters is investigated, with model u... A robust fault diagnosis approach is developed by incorporating a set-membership identification (SMI) method. A class of systems with linear models in the form of fault related parameters is investigated, with model uncertainties and parameter variations taken into account explicitly and treated as bounded errors. An ellipsoid bounding set-membership identification algorithm is proposed to propagate bounded uncertainties rigorously and the guaranteed feasible set of faults parameters enveloping true parameter values is given. Faults arised from abrupt parameter variations can be detected and isolated on-line by consistency check between predicted and observed parameter sets obtained in the identification procedure. The proposed approach provides the improved robustness with its ability to distinguish real faults from model uncertainties, which comes with the inherent guaranteed robustness of the set-membership framework. Efforts are also made in this work to balance between conservativeness and computation complexity of the overall algorithm. Simulation results for the mobile robot with several slipping faults scenarios demonstrate the correctness of the proposed approach for faults detection and isolation (FDI). 展开更多
关键词 set-membership identification fault diagnosis fault detection and isolation (FDI) bounded error mobile robot
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部